Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani During the Launch of the Higher Institute of Heath in USJ: We are Still Far From Achieving Health Equity

 
NNA- Saint Joseph University (USJ) in Beirut launched the Higher Institute of Health in the context of the fourth Edition of "Faculty of medicine Spring", under the auspices and in the presence of Deputy Prime Minister Health Minister Ghassan Hasbani and USJ President Pr. Salim Dacccache S.J., Dean of the Faculty of Medicine Pr. Roland Tanab, Head of the faculty Dr. Michele Kosremelli Asmar and acamedic personalities and other eminent persons in the fields of medicine, syndicates and specializations, as well as students who participated in the "Faculty of Medicine Spring" over two days.
       
Dr. Michele Kosremelli Asmar, Dr. Rana Hajja, Pr.  Roland Tanab and Pr. Salim Dacccache made statements on this occasion.
 
Minister Hasbani started his statement referring to "health catastrophe that could have arisen due to the uncontrolled Syrian displacement. However this crisis has been controlled by making use of the voluntary civil communities expertise, since a large number of diseases has been contained. Such successes contributed in preserving the medical reputation of Lebanon, knowing that Saint Joseph University plays a leading role in this context. In spite of this, we are still facing gaps in our health system and it's our and your responsibility with other partners to deal with them. These gaps include the shortage of emergency medicine and geriatrics services, in addition to the recent gaps in the fields of general insurance. Despite all we spend on Health we are still far from the achievement of health equity."
 
As for smoking, Hasbani noted that he has asked to raise the taxes on tobacco, but his request was rejected under the pretext that it would increase smuggling. He noted also that he would continue improving policies related to general health.
 
It is worth noting that conferences and activities went on for two full days   during which were present eminent persons from Lebanon and abroad such as Pr. Jean-Paul Moatti  and other eminent personalities that took part in the edition of this spring."
    1
ATC Name B/G Ingredients Dosage Form Price
J05AR10 KALUVIA G Lopinavir - 200mg, Ritonavir - 50mg Tablet, film coated 7,632,790 L.L
V06DD KETOSTERIL B Calcium - 0.05g, Total nitrogen - 36mg, L-Tyrosine - 30mg, L-Histidine - 38mg, L-Tryptophan - 23mg, L-Threonine - 53mg, L-Lysine Monoacetate - 105mg, Alpha Hydroxyanalogue-DL-Methionine, Calcium Salt - 59mg, Alpha Ketoanalogue-Valine,Calcium Salt - 86mg, Alpha Ketoanalogue-Phenylalanine,Calcium Salt - 68mg, Alpha-Ketoanalogue- Leucine,Calcium Salt - 101mg, Alpha-Ketoanalogue-DL-isoleucine,Calcium Salt - 67mg Tablet, film coated 3,950,897 L.L
D10AD01 KETREL G Tretinoin - 0.05% 0.05% Cream 397,777 L.L
D07AC13 KONEX G Mometasone furoate - 0.1% 0.1% Solution 385,683 L.L
N03AX14 KEPPRA B Levetiracetam - 1000mg 1,000mg Tablet, film coated 11,749,079 L.L
N03AX14 KEPCITAM G Levetiracetam - 1000mg 1000mg Tablet, film coated 3,119,058 L.L
L01FD03 KADCYLA BioTech Trastuzumab emtansine - 100mg 100mg Injectable powder for concentrate for solution L.L
L01FD03 KADCYLA BioTech Trastuzumab emtansine - 100mg 100mg Injectable powder for concentrate for solution 135,545,977 L.L
M01AE03 KETOPROFENE MACOPHARMA G Ketoprofen - 100mg/100ml 100mg/100ml Injectable solution 329,241 L.L
L01FF02 KEYTRUDA BioTech Pembrolizumab - 100mg/4ml 100mg/4ml Injectable solution L.L
L01FF02 KEYTRUDA BioTech Pembrolizumab - 100mg/4ml 100mg/4ml Injectable solution 241,744,802 L.L
J06BA02 KIOVIG BioHuman Human normal immunoglobulin G - 10g/100ml 10g/100ml Injectable solution 56,495,332 L.L
C03DA05 KERENDIA G Finerenone - 10mg 10mg Tablet, film coated 6,353,687 L.L
M01AB15 KETOLAC G Ketorolac trometamine - 10mg 10mg Tablet 268,769 L.L
N05BA01 KRATIUM G Diazepam - 10mg/2ml 10mg/2ml Injectable solution 537,537 L.L
J01FA09 KLACID B Clarithromycin - 125mg/5ml 125mg/5ml Granules for suspension 575,165 L.L
L01XA02 KARBOTEEN G Carboplatin - 150mg/15ml 150mg/15ml Injectable solution 2,080,268 L.L
L01XA02 KARBOTEEN G Carboplatin - 150mg/15ml 150mg/15ml Injectable solution L.L
R05DB13 KREVAL FORTE G Butamirate citrate - 15mg/5ml 15mg/5ml Syrup 385,683 L.L
L01FD03 KADCYLA BioTech Trastuzumab emtansine - 160mg 160mg Injectable powder for concentrate for solution L.L
L01FD03 KADCYLA BioTech Trastuzumab emtansine - 160mg 160mg Injectable powder for concentrate for solution 216,872,714 L.L
J01CR02 KLAVOX G Amoxicillin (trihydrate) - 875mg, Clavulanic Acid (potassium) - 125mg 1g Tablet, film coated 338,648 L.L
D01AC08 KETOCONAZOLE KORHISPANA G Ketoconazole - 2% 2% Gel 599,354 L.L
L01EF02 KISQALI B Ribociclib - 200mg 200mg Tablet, film coated L.L
L01EF02 KISQALI B Ribociclib - 200mg 200mg Tablet, film coated 200,752,977 L.L
C03DA05 KERENDIA G Finerenone - 20mg 20mg Tablet, film coated 6,353,687 L.L
C07AB05 KERLONE B Betaxolol HCl - 20mg 20mg Tablet, film coated, scored 575,165 L.L
L04AA52 KESIMPTA BioTech Ofatumumab - 20mg/0.4ml 20mg/0.4ml Injectable solution L.L
L04AA52 KESIMPTA BioTech Ofatumumab - 20mg/0.4ml 20mg/0.4ml Injectable solution 94,290,414 L.L
N02BE01 KIDOL-OR G Paracetamol - 240mg/5ml 240mg/5ml Elixir 314,843 L.L
    1
Sitemap
© Copyrights reserved to Ministry of Public Health 2026